• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
540596
INE406M01024
230.6075957
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ERIS
79.59
20214.19
EPS(TTM)
Face Value()
Div & Yield %
18.33
1
0.49
 

Salguti Industries reports standalone net loss of Rs 0.28 crore in the March 2026 quarter
Jun 01,2026
Net loss of Salguti Industries reported to Rs 0.28 crore in the quarter ended March 2026 as against net profit of Rs 0.20 crore during the previous quarter ended March 2025. Sales rose 14.18% to Rs 27.53 crore in the quarter ended March 2026 as against Rs 24.11 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.13 crore in the year ended March 2026 as against net profit of Rs 0.16 crore during the previous year ended March 2025. Sales rose 24.72% to Rs 108.78 crore in the year ended March 2026 as against Rs 87.22 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales27.5324.11 14 108.7887.22 25
OPM %3.315.56 -4.195.01 -
PBDT0.300.65 -54 1.961.74 13
PBT-0.310.16 PL -0.270.08 PL
NP-0.280.20 PL -0.130.16 PL